Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02483572 · ClinicalTrials.gov registry record · NA

Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control

A NA study, sponsored by University of Nebraska.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT02483572: Clinical Trial NA study, sponsored by University of Nebraska.

NCT02483572 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02483572, a NA study, was terminated before completion, sponsored by University of Nebraska.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Children with an intellectual disability often display severe destructive behavior (e.g., aggression, self-injury) that pose risks to themselves or others and represent barriers to community integration. Destructive behaviors are often treated with behavioral interventions derived from a functional analysis, which is used to identify the antecedents and consequences that occasion and reinforce the destructive behavior. One treatment is called functional communication training (FCT), which involves extinction of destructive behavior and reinforcement of an alternative communication response with the consequence that previously reinforced destructive behavior. Results from epidemiological studies and meta-analyses indicate that treatments based on functional analysis, like FCT, typically reduce destructive behavior by 90% or more and are more effective than other treatments. However, many if not all of these studies have used within-subject experimental designs to demonstrate control of the treatment effects. Replication of the effects of FCT is typically shown on a subject-by-subject basis with relatively small numbers of patients (e.g., one to four patients). No study has demonstrated the effectiveness of FCT for treatment of destructive behavior across a large group of children. The goal of this study is to compare FCT (which is used clinically with the majority of the investigators' patients and is considered best practice for treating destructive behavior that occurs for social reasons \[e.g., to access attention, preferred toys, or to escape from unpleasant activities\]) to a waitlist control group across a large number of children with destructive behavior to evaluate the generality of FCT effectiveness. The investigators will evaluate rates of destructive behavior with each patient during a pretest baseline and again following FCT (approximately four months later) and/or the waitlist control duration (again, approximately four months later). All children assi

Primary Outcome

The investigators will measure the rate of destructive behavior following successful treatment when implemented by participants' caregivers. Participants assigned to the wait-list control group will have their rate of destructive behavior assessed at the end of the wait period, prior to implementing treatment, to detect any changes in rate of destructive behavior due to the passage of time.

Interventions

  • BEHAVIORAL Functional Communication Training

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2016-09-01
Est. Completion 2019-01-25
Phase NA
University of Nebraska

407 total trials

Why NCT02483572 stopped before completion

NCT02483572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Functional Communication Training is the first listed.

NCT02483572 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02483572 about?

NCT02483572 is a clinical study titled "Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control". Children with an intellectual disability often display severe destructive behavior (e.g., aggression, self-injury) that pose risks to themselves or others and represent barriers to community integration. Destructive behaviors are often treated with behavioral interventions derived from a functional ...

What is the current status of trial NCT02483572?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-09-01. Estimated completion is 2019-01-25.

What interventions are being tested in trial NCT02483572?

The interventions under investigation include: Functional Communication Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02483572?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02483572's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02483572, the US trial registry maintained by the National Library of Medicine. NCT02483572 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.